Q-omics provides the consensus-scored LINC01911 profile across patient tissues and cancer cell-line models. LINC01911 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in ESCA. Additionally, LINC01911 RNA expression shows 5,335 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ESCA, and STAD as cancer lineages where LINC01911 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for LINC01911 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes LINC01911 survival associations across molecular data types. LINC01911 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

LINC01911 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	9	LIHC (36)	view →

This table ranks reproducible LINC01911 RNA expression–survival associations across cancer types. High LINC01911 expression shows unfavorable associations in LIHC, TGCT, KIRP, LUSC and STAD, but favorable associations in ESCA. The ESCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .016). Together, the overview and detailed table identify ESCA as the clearest survival context for LINC01911 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	III,IV	0.676	0.249	.016	36	view →
LIHC	OS	Tertile	II,III,IV	0.118	0.716	.003	36	view →
TGCT	DFS	Tertile	II,III,IV	0.638	0.996	.005	30	view →
KIRP	OS	Tertile	All	0.317	0.737	.016	21	view →
LUSC	OS	Tertile	All	0.490	0.742	.026	18	view →
STAD	DFS	Tertile	II,III,IV	0.328	0.698	.030	18	view →

Pink = unfavorable, green = favorable. all 9 lineages →

LINC01911-ESCA (DFS)

Kaplan–Meier survival curve for LINC01911 RNA expression in ESCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with LINC01911 in patient tissues and cancer cell lines. In patient samples, LINC01911 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,335	STAD (5051)	view →
RNA	4,014	COAD (1468)	view →